Form 8-K ANTARES PHARMA, INC. For: May 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/1/2026
- S&P 500, Nasdaq register best quarter since 2020 despite Iran war
- Dollar pushes higher, yen sinks to 40-year low
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
- Citi says bearish flows are building in Nasdaq and S&P 500
- Patrick and LCI Industries to merge in all-stock deal
- S&P 500, Nasdaq register best quarter since 2020 despite Iran war
- DISH DBS files prepackaged chapter 11 to repay debt, wind down wireless
- Cantor Fitzgerald Starts Forward Industries (FWDI) at Overweight
- Boeing commercial jet deliveries and production disrupted by widespread IT outage - Air Current
- NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
Antares Pharma (ATRS) Reports In-Line Q1 EPS
May 11, 2015 8:40 AM EDTAntares Pharma (NASDAQ: ATRS) reported Q1 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $8.3 million versus the consensus estimate of $9.22 million.
For earnings history and earnings-related data on Antares Pharma (ATRS) click here.
... More